Cue Biopharma, Inc. Increase (Decrease) in Deposits
Cue Biopharma, Inc. (CUE) reported Increase (Decrease) in Deposits of -$787.27 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeposits · last filed 2019-08-08
- Cue Biopharma, Inc. increase (decrease) in deposits for the quarter ending 2018-12-31 was -$236.27K, a 567.24% decline year-over-year.
- Cue Biopharma, Inc. increase (decrease) in deposits for the quarter ending 2018-09-30 was $0.00.
- Cue Biopharma, Inc. increase (decrease) in deposits for the quarter ending 2018-06-30 was $509.00K.
- Cue Biopharma, Inc. increase (decrease) in deposits for the quarter ending 2018-03-31 was -$1.06M.
- Cue Biopharma, Inc. increase (decrease) in deposits for fiscal 2018 was -$787.27K.
- Cue Biopharma, Inc. increase (decrease) in deposits for fiscal 2017 was -$58.43K.
| Period end | Increase (Decrease) in Deposits 3 month | Increase (Decrease) in Deposits 6 month | Increase (Decrease) in Deposits 9 month | Increase (Decrease) in Deposits 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$236.27K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$236.27K derived: sum of 2 quarters · filed 2019-03-14 | $272.73K derived: sum of 3 quarters · filed 2019-08-08 | -$787.27K 10-K · filed 2019-03-14 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $509.00K derived: sum of 2 quarters · filed 2019-08-08 | -$551.00K 10-Q · filed 2018-11-13 | -$500.43K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$551.00K 10-Q · filed 2019-08-08 | -$500.43K derived: sum of 3 quarters · filed 2019-08-08 | -$508.43K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$1.06M 10-Q · filed 2019-05-08 | -$1.01M derived: sum of 2 quarters · filed 2019-05-08 | -$1.02M derived: sum of 3 quarters · filed 2019-05-08 | -$1.02M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $50.57K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $42.57K derived: sum of 2 quarters · filed 2019-03-14 | $42.57K derived: sum of 3 quarters · filed 2019-03-14 | -$58.43K 10-K · filed 2019-03-14 |
| 2017-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$8.00K derived: sum of 2 quarters · filed 2018-11-13 | -$109.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$101.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | -$101.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |